Literature DB >> 24382222

Saturated fatty acid induces insulin resistance partially through nucleotide-binding oligomerization domain 1 signaling pathway in adipocytes.

Yi-jun Zhou, Yin-si Tang1, Yu-ling Song1, Ai Li1, Hui Zhou1, Yan Li1.   

Abstract

OBJECTIVE: To investigate the potential role of nucleotide-binding oligomerization domain 1 (NOD1), a component of the innate immune system, in mediating lipid-induced insulin resistance in adipocytes.
METHODS: Adipocytes from Toll-like receptor 4 deficiency mice were used for stimulation experiments. The effect of oleate/palmitate mixture on nuclear factor-κB (NF-κB) activation was analyzed by reporter plasmid assay. The release of proinflammatory chemokine/cytokines production was determined by using real-time PCR. Insulin-stimulated glucose uptake was measured by 2-deoxy-D-[3H] glucose uptake assay. Chemokine/cytokine expression and glucose uptake in adipocytes transfected with small interfering RNA (siRNA) targeting NOD1 upon fatty acids treatment were analyzed.
RESULTS: Oleate/palmitate mixture activated the NF-κB pathway and induced interleukin-6, tumor necrosis factor-α, and monocyte chemoattractant protein-1 mRNA expressions in adipocytes from mice deficient in Toll-like receptor 4, and these effects were blocked by siRNA targeting NOD1. Furthermore, saturated fatty acids decreased the ability of insulin-stimulated glucose uptake. Importantly, siRNA targeting NOD1 partially reversed saturated fatty acid-induced suppression of insulin-induced glucose uptake.
CONCLUSION: NOD1 might play an important role in saturated fatty acid-induced insulin resistance in adipocytes, suggesting a mechanism by which reduced NOD1 activity confers beneficial effects on insulin action.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24382222     DOI: 10.1016/s1001-9294(14)60004-3

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  7 in total

Review 1.  NOD1: An Interface Between Innate Immunity and Insulin Resistance.

Authors:  Sydney L Rivers; Amira Klip; Adria Giacca
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 2.  NOD1 and NOD2: Beyond Peptidoglycan Sensing.

Authors:  A Marijke Keestra-Gounder; Renée M Tsolis
Journal:  Trends Immunol       Date:  2017-08-16       Impact factor: 16.687

Review 3.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

4.  Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process.

Authors:  Liliana Perdomo; Nuria Beneit; Yolanda F Otero; Óscar Escribano; Sabela Díaz-Castroverde; Almudena Gómez-Hernández; Manuel Benito
Journal:  Cardiovasc Diabetol       Date:  2015-06-10       Impact factor: 9.951

Review 5.  Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders.

Authors:  Priscila Silva Figueiredo; Aline Carla Inada; Gabriela Marcelino; Carla Maiara Lopes Cardozo; Karine de Cássia Freitas; Rita de Cássia Avellaneda Guimarães; Alinne Pereira de Castro; Valter Aragão do Nascimento; Priscila Aiko Hiane
Journal:  Nutrients       Date:  2017-10-22       Impact factor: 5.717

Review 6.  Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2.

Authors:  Megan T Zangara; Isabel Johnston; Erin E Johnson; Christine McDonald
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

Review 7.  Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes.

Authors:  Justin Hou Ming Yung; Adria Giacca
Journal:  Cells       Date:  2020-03-13       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.